COMPARATIVE EFFECTS OF METHOTREXATE, 2 NON-CLASSIC FOLIC-ACID ANTAGONISTS, AND CYTARABINE ON HEMATOPOIETIC PRECURSOR CELLS
- 1 January 1982
- journal article
- research article
- Vol. 66 (3) , 499-504
Abstract
The effects of 3 antifolates, methotrexate (MTX), triazinate (TZT), and a trimethoxyquinazoline derivative (TMQ), and of cytarabine (ara-C) on leukocyte-committed colony-forming cells from 3 spp. were compared using an assay allowing in vivo metabolism in an agar diffusion chamber. Dose-survival curves approximated plateaus and the level of the plateau was variable among species. Canine marrow colony-forming cells were less sensitive to MTX (.apprx. 90% survival) than those from mice or man (25-40% survival). Human marrow colony-forming cells were less sensitive (70% survival) to TZT than those from mice or dogs (25% survival). No interspecies differences were found for TMQ or ara-C. Mouse marrow in situ was less sensitive to i.v. MTX than mouse marrow in the chamber. No such difference was found for i.v. TMQ or ara-C. This comparison could not be made for i.p. TZT. [Myelosuppression is one of the major toxic effects of the antifolates.].This publication has 6 references indexed in Scilit:
- 2,4-Diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline (TMQ), a potent non-classical folate antagonist inhibitor—IBiochemical Pharmacology, 1979
- COMPARISON OF THE SENSITIVITIES OF HUMAN, CANINE, AND MURINE HEMATOPOIETIC PRECURSOR CELLS TO ADRIAMYCIN AND N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE1979
- PHASE-2 STUDY WITH BAKERS ANTIFOL IN SOLID TUMORS1977
- Phase i studies with baker's antifol (baf) (nsc 139105)Cancer, 1976
- Changes in proliferation rate of human bone marrow colony-forming cells measured by a cytosine arabinoside-diffusion chamber methodPublished by Elsevier ,1976
- SENSITIVITIES OF HUMAN AND MURINE HEMATOPOIETIC CELLS EXPOSED TO CYTOTOXIC DRUGS IN AN INVIVO CULTURE SYSTEM1976